AMJ

06/06/2026

Global pediatric skin disease burden rose significantly from 1990 to 2021, but why?

Find out on AMJ:

Pediatric skin disease burden is rising globally, driven by acne and atopic dermatitis. Read more.

06/05/2026

How patients use cannabis may matter more than how often they use it.

A study of nearly 59 million adults found that smoking, va**ng, or combining multiple methods was linked to a significantly higher risk of cannabis use disorder, while edibles and topical products carried a lower risk.

Explore the findings: https://hubs.la/Q04kg_qP0

06/05/2026

As AI continues to evolve, dermatology is exploring how these tools can be integrated safely and effectively into clinical practice.

This 2026 congress feature examines the opportunities, challenges, and considerations shaping the future of augmented intelligence in dermatology.

Read more: https://hubs.la/Q04kf17Z0

Speaker is AI generated.

06/05/2026

Hispanic outdoor workers face elevated skin cancer risk - and very few tailored educational resources are available.

A new co-designed video aims to change that.

Learn more: https://hubs.la/Q04k2CGs0

06/05/2026

New research: Disrupted sleep physiology may affect how quickly we recognize emotions in others.

Learn more: https://hubs.la/Q04k2LJX0

06/04/2026

Our latest AMJ Neurology Journal is now live. 🧠🚨

In this video, our Editor, Anaya, breaks down the practice-changing research shaping the future of patient care. From landmark updates straight from AAN 2026 to clinical insights you can implement today, your peers are already diving in.

What you need to know right now:
🔬 MS Care: What BTK inhibition really means for your patients.
🌀 Migraine Management: How vestibular rehabilitation is transforming outcomes.
☀️ Headache Triggers: A landmark finding linking daylight exposure in youth directly to headache frequency.

This is the research that shifts thinking, changes practice, and ultimately changes lives. All backed by over 100 world-class experts and 8 evidence-based abstract reviews.

It’s free. It’s live. Don’t get left behind.

Read the full journal now: https://hubs.la/Q04k2ZQV0

06/04/2026

Higher BMI was linked to a smaller sex-related difference in lung cancer survival.

Researchers found the survival advantage typically seen in female patients was less pronounced among those with higher BMI, raising new questions about the role of body composition in cancer outcomes.

Read more: https://hubs.la/Q04k1McK0

06/02/2026

Could a new standard of care be on the horizon for pancreatic cancer?

AMJ editor Anaya is at , where Day 3 discussions were dominated by the Phase III RASolute 302 trial, which delivered promising results for patients with pancreatic cancer.

The impact of the findings was clear, with the plenary session concluding in a standing ovation as delegates recognised the potential significance of the data.

Looking for the key takeaways from ASCO 2026? Join AMJ for expert insights direct from congress: https://hubs.ly/Q04jPQlS0

06/02/2026

New therapies are reshaping the future of respiratory care.

From slowing lung function decline in idiopathic pulmonary fibrosis to advancing treatment options for MAC lung disease and pulmonary arterial hypertension, ATS 2026 delivered promising insights across respiratory medicine.

Explore the highlights and read more on AMJ Respiratory: https://hubs.la/Q04jNrlG0

06/01/2026

Day 2 at has brought fresh insights into the evolving role of precision oncology in cancer care.

AMJ editor Anaya is reporting from Chicago, where Sunday's plenary session explored how personalised treatment approaches are continuing to move earlier in the treatment process.

Hear what experts are saying on the ground and explore the latest congress updates via the link below: https://hubs.la/Q04jzDt80